HIV Study Among Top Ten Breakthroughs of 2020

Science magazine’s annual research list includes landmark study of elite controllers

• New amfAR Grants Target Intersection of HIV and COVID-19
• Prospects for an HIV/AIDS Cure: Opinions of People with HIV and Their Healthcare Providers
• What Are the COVID Risks for People Living with HIV?

FDA Approves Long-Acting Injectable to Treat HIV

Monthly regimen can replace daily pills for individuals on treatment with undetectable virus

• PEPFAR in the Age of COVID-19 -- The Need for Supplemental Funding
• Deaths Related to HIV Drop by Half in U.S.
• amfAR Study Wins Elsevier Atlas Award

ViiV Healthcare and TREAT Asia Partner on Important New Study of Young Adults with HIV

amfAR’s TREAT Asia program to address key questions concerning transition from pediatric to adult care

• amfAR’s Greg Millett Presents at Smithsonian World AIDS Day Event
• Global Anti-HIV Drug Supplies Running Low
• COVID-19 Pandemic Threatens HIV Drug Supplies

Connections - Episode 3: COVID & HIV – Maria Davis

Maria Davis has dedicated her life to being an educator, advocate, and activist on behalf of people living with HIV. We reconnected with Maria for National Black HIV/AIDS Awareness Day on February 7,

COVID-19 and HIV/AIDS

We are constantly gathering new information to keep you up to date on the intersection between HIV and COVID-19. The hard-won lessons of HIV research are informing the race to find effective treatments and a vaccine for COVID-19.

Compassionate Physician, Pioneering Researcher

Dr. Sonnabend was a co-founder, with Dr. Mathilde Krim and others, of the AIDS Medical Foundation, amfAR’s predecessor.

Pioneering amfAR-Funded Study Underway

A potentially groundbreaking clinical trial will test a combination HIV cure strategy.